Piotr Rozentryt

4.1k total citations · 1 hit paper
92 papers, 2.6k citations indexed

About

Piotr Rozentryt is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Piotr Rozentryt has authored 92 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Cardiology and Cardiovascular Medicine, 15 papers in Nephrology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Piotr Rozentryt's work include Heart Failure Treatment and Management (26 papers), Cardiovascular Function and Risk Factors (19 papers) and Cardiac pacing and defibrillation studies (9 papers). Piotr Rozentryt is often cited by papers focused on Heart Failure Treatment and Management (26 papers), Cardiovascular Function and Risk Factors (19 papers) and Cardiac pacing and defibrillation studies (9 papers). Piotr Rozentryt collaborates with scholars based in Poland, Germany and Italy. Piotr Rozentryt's co-authors include Piotr Ponikowski, Lech Poloński, Stephan von Haehling, Ewa A. Jankowska, Jolanta Nowak, Wolfram Doehner, Gerasimos Filippatos, Beata Ponikowska, Oliver Hartmann and Ludmiła Borodulin- Nadzieja and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Piotr Rozentryt

87 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Iron deficiency: an ominous sign in patients with systolic chronic heart failure

2010 481 citations Ewa A. Jankowska, Piotr Rozentryt et al. profile →

Peers

Countries citing papers authored by Piotr Rozentryt

Since Specialization

Citations

This map shows the geographic impact of Piotr Rozentryt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piotr Rozentryt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piotr Rozentryt more than expected).

Fields of papers citing papers by Piotr Rozentryt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piotr Rozentryt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piotr Rozentryt. The network helps show where Piotr Rozentryt may publish in the future.

Co-authorship network of co-authors of Piotr Rozentryt

This figure shows the co-authorship network connecting the top 25 collaborators of Piotr Rozentryt. A scholar is included among the top collaborators of Piotr Rozentryt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piotr Rozentryt. Piotr Rozentryt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term prognostic scores may underestimate the risk of death in patients with heart failure with reduced ejection fraction in whom red cells distribution width is elevated 2023 ·Polskie Archiwum Medycyny Wewnętrznej ·(unknown), (unknown), Jolanta Nowak, (unknown), (unknown), (unknown), (unknown), (unknown), Jacek Niedziela, Michał Skrzypek, Mariusz Gąsior, Piotr Rozentryt	0
2	Sodium-Glucose Cotransporter-2 Inhibitors-from the Treatment of Diabetes to Therapy of Chronic Heart Failure 2022 ·Journal of Cardiovascular Development and Disease ·(unknown), Bartosz Hudzik, (unknown), (unknown), Jolanta Nowak, Andrzej Tomasik, (unknown), Piotr Rozentryt, Mariusz Gąsior	5
3	Risk factors for surgical site infection in patients after implant-related orthopedic procedures 2022 ·Przeglad Epidemiologiczny ·(unknown), Piotr Rozentryt, (unknown)	3
4	Cardiorenal syndrome: Decongestion in heart failure across wide spectrum of kidney pathophysiology 2022 ·Advances in Clinical and Experimental Medicine ·(unknown), Jan Biegus, Piotr Rozentryt, Magdalena Hurkacz, Robert Zymliński	6
5	Expert opinion of the Heart Failure Working Group of the Polish Cardiac Society on the use of dapagliflozin in the treatment of heart failure with reduced ejection fraction 2021 ·Kardiologia Polska ·Jadwiga Nessler, Aleksander Siniarski, Przemysław Leszek, Janusz Gumprecht, Jarosław Dróżdż, Jarosław Kaźmierczak, Adam Witkowski, Andrzej Gackowski, Ewa A. Jankowska, Tomasz Kukulski, Małgorzata Lelonek, Piotr Rozentryt, Paweł Rubiś, Piotr Ponikowski	11
6	The patient with heart failure in the face of the coronavirus disease 2019 pandemic: an expert opinion of the Heart Failure Working Group of the Polish Cardiac Society 2020 ·Kardiologia Polska ·Marta Kałużna‐Oleksy, Andrzej Gackowski, Ewa A. Jankowska, Tomasz Kukulski, Małgorzata Lelonek, Jadwiga Nessler, Agnieszka Pawlak, Piotr Rozentryt, Paweł Rubiś, Ewa Straburzyńska‐Migaj, Przemysław Leszek	7
7	Clinical correlates and prognostic impact of impaired iron storage versus impaired iron transport in an international cohort of 1821 patients with chronic heart failure 2017 ·International Journal of Cardiology ·Pedro Moliner, Ewa A. Jankowska, Dirk J. van Veldhuisen, Núria Farré, Piotr Rozentryt, Cristina Enjuanes, Lech Poloński, Oona Meroño, Adriaan A. Voors, Piotr Ponikowski, Peter van der Meer, Josep Comín‐Colet	51
8	Sacubitril/valsartan for treatment of chronic heart failure with reduced ejection fraction. Can all patients benefit? A position statement paper of experts of the Heart Failure Working Group of the Polish Cardiac Society 2017 ·Kardiologia Polska ·Ewa Straburzyńska‐Migaj, Jadwiga Nessler, Marcin Gruchała, Karol Kamiński, Małgorzata Lelonek, Przemysław Leszek, Katarzyna Mizia‐Stec, Piotr Rozentryt, Andrzej Gackowski, Adrian Gwizdała, Ewa A. Jankowska, Piotr Ponikowski	1
9	Renal function on admission affects both treatment strategy and long-term outcomes of patients with myocardial infarction (from the Polish Registry of Acute Coronary Syndromes) 2017 ·Kardiologia Polska ·Michał Hawranek, Marek Gierlotka, Mariusz Gąsior, Bartosz Hudzik, Piotr Desperak, (unknown), Mateusz Tajstra, Tadeusz Osadnik, Piotr Rozentryt, Lech Poloński	15
10	Clinical and laboratory determinants of 25-hydroxyvitamin D deficiency during pharmacotherapeutic escalation in heart failure patients 2015 ·Polish Journal of Cardio-Thoracic Surgery ·Krzysztof Myrda, Piotr Rozentryt, Jacek Niedziela, (unknown), (unknown), Bartosz Hudzik, Jolanta Nowak, Mariusz Gąsior	1
11	COnteMporary Modalities In Treatment of Heart Failure: a report from the COMMIT-HF registry 2015 ·Kardiologia Polska ·Mariusz Gąsior, Łukasz Pyka, (unknown), Michał Hawranek, Mateusz Tajstra, (unknown), Anna Kurek, Adam Krajewski, Piotr Rozentryt, Marek Gierlotka, Andrzej Lekston, Marian Zembala, Lech Poloński	9
12	The Additive Burden of Iron Deficiency in the Cardiorenal–Anaemia Axis: Scope of a Problem and its Consequences 2014 ·European Journal of Heart Failure ·IJsbrand T. Klip, Ewa A. Jankowska, Cristina Enjuanes, Adriaan A. Voors, Waldemar Banasiak, Jordi Bruguera, Piotr Rozentryt, Lech Poloński, Dirk J. van Veldhuisen, Piotr Ponikowski, Josep Comín‐Colet, Peter van der Meer	58
13	The obesity paradox in acute coronary syndrome: a meta-analysis 2014 ·European Journal of Epidemiology ·Jacek Niedziela, Bartosz Hudzik, Natalia Niedziela, Mariusz Gąsior, Marek Gierlotka, Jarosław Wasilewski, Krzysztof Myrda, Andrzej Lekston, Lech Poloński, Piotr Rozentryt	193
14	HIGH SOLUBLE TRANSFERRIN RECEPTOR IN PATIENTS WITH SYSTOLIC HEART FAILURE: A MEASURE OF IRON DEFICIENCY AND A STRONG PREDICTOR OF MORTALITY 2013 ·Journal of the American College of Cardiology ·Ewa A. Jankowska, Tomasz Suchocki, (unknown), Grzegorz Mazur, Aleksandra Butrym, Ilona Rybińska, Piotr Rozentryt, Peter van der Meer, Josep Comín‐Colet, IJsbrand T. Klip, Adriaan A. Voors, Waldemar Banasiak, Piotr Ponikowski	2
15	Identification of Chronic Heart Failure Patients with a High 12-Month Mortality Risk Using Biomarkers Including Plasma C-Terminal Pro-Endothelin-1 2011 ·PLoS ONE ·Ewa A. Jankowska, Gerasimos Filippatos, Stephan von Haehling, Jana Papassotiriou, Nils G. Morgenthaler, Mariantonietta Cicoira, Joerg C. Schefold, Piotr Rozentryt, Beata Ponikowska, Wolfram Doehner, Waldemar Banasiak, Oliver Hartmann, Joachim Struck, Andreas Bergmann, Stefan D. Anker, Piotr Ponikowski	34
16	Mid-Regional Pro-Adrenomedullin as a Novel Predictor of Mortality in Patients with Chronic Heart Failure 2010 ·European Journal of Heart Failure ·Stephan von Haehling, Gerasimos Filippatos, Jana Papassotiriou, Mariantonietta Cicoira, Ewa A. Jankowska, Wolfram Doehner, Piotr Rozentryt, Corrado Vassanelli, Joachim Struck, Waldemar Banasiak, Piotr Ponikowski, Dimitrios Th. Kremastinos, Andreas Bergmann, Nils G. Morgenthaler, Stefan D. Anker	111
17	Dzielimy się doświadczeniem The assessment of left and right ventricular function in patients with severe pulmonary diseases 2007 ·Jolanta Nowak, Tomasz Kukulski, (unknown), Piotr Rozentryt, Dariusz Jastrzębski, Jacek Wojarski, Marian Zembala	1
18	Prognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart Failure 2007 ·Journal of the American College of Cardiology ·Tibor Kempf, Stephan von Haehling, Timo Peter, Tim Allhoff, Mariantonietta Cicoira, Wolfram Doehner, Piotr Ponikowski, Gerasimos Filippatos, Piotr Rozentryt, Helmut Drexler, Stefan D. Anker, Kai C. Wollert	392
19	Comparison of Midregional Pro-Atrial Natriuretic Peptide With N-Terminal Pro-B-Type Natriuretic Peptide in Predicting Survival in Patients With Chronic Heart Failure 2007 ·Journal of the American College of Cardiology ·Stephan von Haehling, Ewa A. Jankowska, Nils G. Morgenthaler, Corrado Vassanelli, Luisa Zanolla, Piotr Rozentryt, Gerasimos Filippatos, Wolfram Doehner, Friedrich Koehler, Jana Papassotiriou, Dimitrios Th. Kremastinos, Waldemar Banasiak, Joachim Struck, Piotr Ponikowski, Andreas Bergmann, Stefan D. Anker	123
20	Niewydolność serca i płuc, transplantologia Prognosis of patients with advanced heart failure referred for heart transplantation – data of POLKARD heart failure registry 2003–2005 2006 ·J Korewicki, (unknown), Tomasz Zieliński, Małgorzata Sobieszczańska‐Małek, Małgorzata Piotrowska, Marian Zembala, Michał Zakliczyńśki, Piotr Rozentryt, (unknown), Jerzy Sadowski, Piotr Przybyłowski, (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact